Ardavanis A - Search Results

1

Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).

Alexopoulos A, Karanikiotis C, Ardavanis A, Boukovinas I, Makrantonakis P, Papadimitriou C, Athanasiadis A, Boutis A, Giassas S, Kakolyris S, Koumakis G, Papazisis K, Psyrri A, Ziras N, Baka S, Kentepozidis N, Michalaki V. Alexopoulos A, et al. Among authors: ardavanis a. Anticancer Res. 2022 Feb;42(2):1031-1041. doi: 10.21873/anticanres.15564. Anticancer Res. 2022. PMID: 35093904

2

Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer.

Ardavanis A, Scorilas A, Amanatidou A, Gerakini F, Missitzis I, Garoufali A, Pissakas G, Pateras C, Apostolikas N, Rigatos G, Yiotis I. Ardavanis A, et al. Anticancer Res. 1997 Mar-Apr;17(2B):1405-9. Anticancer Res. 1997. PMID: 9137506

3

Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance.

Ardavanis A, Gerakini F, Amanatidou A, Scorilas A, Pateras C, Garoufali A, Pissakas G, Stravolemos K, Apostolikas N, Yiotis I. Ardavanis A, et al. Anticancer Res. 1997 Sep-Oct;17(5A):3665-9. Anticancer Res. 1997. PMID: 9413220

4

Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.

Ardavanis A, Scorilas A, Loukeri A, Gerakini F, Pissakas G, Missitzis I, Apostolikas N, Yiotis I. Ardavanis A, et al. Anticancer Res. 1998 Jul-Aug;18(4B):2885-90. Anticancer Res. 1998. PMID: 9713481

5

HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D.

Korkolis D, Ardavanis A, Yotis J, Kyroudi A, Gorgoulis V, Kittas C. Korkolis D, et al. Among authors: ardavanis a. Anticancer Res. 2001 May-Jun;21(3C):2207-12. Anticancer Res. 2001. PMID: 11501848

6

Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.

Mavroudis D, Alexopoulos A, Malamos N, Ardavanis A, Kandylis C, Stavrinidis E, Kouroussis Ch, Agelaki S, Androulakis N, Bozionelou V, Georgoulias V. Mavroudis D, et al. Among authors: ardavanis a. Oncology. 2003;64(3):207-12. doi: 10.1159/000069306. Oncology. 2003. PMID: 12697959 Clinical Trial.

7

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.

Souglakos J, Androulakis N, Mavroudis D, Kourousis C, Kakolyris S, Vardakis N, Kalbakis K, Pallis A, Ardavanis A, Varveris C, Georgoulias V. Souglakos J, et al. Among authors: ardavanis a. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1284-7. doi: 10.1016/s0360-3016(03)00275-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12873672 Clinical Trial.

8

Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer.

Alexopoulos A, Tryfonopoulos D, Karamouzis MV, Gerasimidis G, Karydas I, Kandilis K, Stavrakakis J, Stavrinides H, Georganta C, Ardavanis A, Rigatos G. Alexopoulos A, et al. Among authors: ardavanis a. Ann Oncol. 2004 Jan;15(1):95-9. doi: 10.1093/annonc/mdh028. Ann Oncol. 2004. PMID: 14679126 Free article. Clinical Trial.

9

Phase II study of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer.

Alexopoulos A, Karamouzis MV, Stavrinides H, Ardavanis A, Kandilis K, Stavrakakis J, Georganta C, Rigatos G. Alexopoulos A, et al. Among authors: ardavanis a. Ann Oncol. 2004 Jun;15(6):891-5. doi: 10.1093/annonc/mdh218. Ann Oncol. 2004. PMID: 15151945 Free article. Clinical Trial.

10

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.

Georgoulias V, Kouroussis C, Agelidou A, Boukovinas I, Palamidas P, Stavrinidis E, Polyzos A, Syrigos K, Veslemes M, Toubis M, Ardavanis A, Tselepatiotis E, Vlachonikolis I; Lung Cancer Committee of the Hellenic Oncology Research Group. Georgoulias V, et al. Among authors: ardavanis a. Br J Cancer. 2004 Aug 2;91(3):482-8. doi: 10.1038/sj.bjc.6602010. Br J Cancer. 2004. PMID: 15238986 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page